106 related articles for article (PubMed ID: 5923255)
21. Susceptibility of mice to experimental staphylococcal pyelonephritis after treatment with some antibacterial agents.
Toivanen P; Toivanen A
Bibl Microbiol; 1966; 5():38-45. PubMed ID: 5957403
[No Abstract] [Full Text] [Related]
22. Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase.
Aratani Y; Kura F; Watanabe H; Akagawa H; Takano Y; Suzuki K; Maeda N; Koyama H
J Infect Dis; 2000 Oct; 182(4):1276-9. PubMed ID: 10979934
[TBL] [Abstract][Full Text] [Related]
23. [Lung infections in immunodepressed patients].
Jemni L; Hmouda H
Tunis Med; 1994; 72(6-7):406-11. PubMed ID: 7871596
[No Abstract] [Full Text] [Related]
24. Biologic contaminants.
Seltzer JM
Occup Med; 1995; 10(1):1-25. PubMed ID: 7792669
[TBL] [Abstract][Full Text] [Related]
25. The effects of alcohol on immunity and bacterial infection in the lung.
Gamble L; Mason CM; Nelson S
Med Mal Infect; 2006 Feb; 36(2):72-7. PubMed ID: 16413723
[TBL] [Abstract][Full Text] [Related]
26. Regulation of phagocyte lifespan in the lung during bacterial infection.
Dockrell DH; Whyte MK
J Leukoc Biol; 2006 May; 79(5):904-8. PubMed ID: 16478918
[TBL] [Abstract][Full Text] [Related]
27. [Pathogenesis of acute destructive lung processes of staphylococcal etiology].
Muromskiĭ IuA; Egorkina DA; Savitskaia KI
Vestn Khir Im I I Grek; 1981 Mar; 126(3):16-9. PubMed ID: 6894507
[TBL] [Abstract][Full Text] [Related]
28. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.
Wu H; Song Z; Hentzer M; Andersen JB; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2004 Jun; 53(6):1054-61. PubMed ID: 15117922
[TBL] [Abstract][Full Text] [Related]
29. Glucan alteration of pulmonary antibacterial defense.
Kimura A; Sherwood RL; Goldstein E
J Reticuloendothel Soc; 1983 Jul; 34(1):1-11. PubMed ID: 6876030
[TBL] [Abstract][Full Text] [Related]
30. [Natural and experimental staphylococcal infections in ducks. Strain characteristics].
Hummel R; Jung S; Eisengarten HJ
Arch Exp Veterinarmed; 1982; 36(6):933-42. PubMed ID: 7168611
[No Abstract] [Full Text] [Related]
31. EXPERIMENTAL STAPHYLOCOCCAL INFECTION OF THE SUBCUTANEOUS TISSUE OF THE MOUSE. I. BACTERIAL POPULATION CHANGES IN RELATION TO TISSUE RESPONSE.
FISHER S; ROBSON JE
J Infect Dis; 1963; 113():204-12. PubMed ID: 14080830
[No Abstract] [Full Text] [Related]
32. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.
Stark JM; Stark MA; Colasurdo GN; LeVine AM
J Med Virol; 2006 Jun; 78(6):829-38. PubMed ID: 16628585
[TBL] [Abstract][Full Text] [Related]
33. Protection against mycoplasma infection using expression-library immunization.
Barry MA; Lai WC; Johnston SA
Nature; 1995 Oct; 377(6550):632-5. PubMed ID: 7566175
[TBL] [Abstract][Full Text] [Related]
34. Vaccination by aerosols: modulation of clearance mechanisms in the lung.
Hensel A; Lubitz W
Behring Inst Mitt; 1997 Feb; (98):212-9. PubMed ID: 9382742
[TBL] [Abstract][Full Text] [Related]
35. [The cloning and expression of rhlR, a quorum sensing gene in Pseudomonas aeruginosa PAO1, and a study of its effect on bacterial clearance rate in mouse lung].
Du BZ; Xie Y; Jia WX; Yang FL; Zeng W; Yang WQ; Cheng X; Chen T; Zhang ZR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):661-5. PubMed ID: 17037722
[TBL] [Abstract][Full Text] [Related]
36. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
[TBL] [Abstract][Full Text] [Related]
37. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens.
Davidson DJ; Dorin JR; McLachlan G; Ranaldi V; Lamb D; Doherty C; Govan J; Porteous DJ
Nat Genet; 1995 Apr; 9(4):351-7. PubMed ID: 7540910
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of mice to experimental staphylococcal pyelonephritis after treatment with mercaptomerin, hydrochlorothiazide or acetazolamide.
Toivanen A; Toivanen P
Bibl Microbiol; 1966; 5():32-7. PubMed ID: 5957402
[No Abstract] [Full Text] [Related]
39. [Clinical assessment of localized forms of staphylococcal infection].
Morgunov IN; Bordonos VG; Pavlenko VA
Vrach Delo; 1982 Sep; (9):111-3. PubMed ID: 7179899
[No Abstract] [Full Text] [Related]
40. Importance of Staphylococcus aureus in allergy in a rural environment.
Laborie F; Laborie R
Allergol Immunopathol (Madr); 1980; 8(5):587-602. PubMed ID: 7468398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
